JP2022514537A5 - - Google Patents
Info
- Publication number
- JP2022514537A5 JP2022514537A5 JP2021534215A JP2021534215A JP2022514537A5 JP 2022514537 A5 JP2022514537 A5 JP 2022514537A5 JP 2021534215 A JP2021534215 A JP 2021534215A JP 2021534215 A JP2021534215 A JP 2021534215A JP 2022514537 A5 JP2022514537 A5 JP 2022514537A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- salcardin
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779056P | 2018-12-13 | 2018-12-13 | |
| US62/779,056 | 2018-12-13 | ||
| US201962858324P | 2019-06-06 | 2019-06-06 | |
| US62/858,324 | 2019-06-06 | ||
| PCT/US2019/066003 WO2020123824A1 (en) | 2018-12-13 | 2019-12-12 | Sulcardine administration for treatment of acute atrial fibrillation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022514537A JP2022514537A (ja) | 2022-02-14 |
| JP2022514537A5 true JP2022514537A5 (https=) | 2022-12-19 |
Family
ID=69165588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534215A Pending JP2022514537A (ja) | 2018-12-13 | 2019-12-12 | 急性心房細動の処置のためのサルカルディン投与 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11364223B2 (https=) |
| EP (1) | EP3893870A1 (https=) |
| JP (1) | JP2022514537A (https=) |
| KR (1) | KR20210135990A (https=) |
| CN (1) | CN113453677A (https=) |
| AU (1) | AU2019397511B2 (https=) |
| CA (1) | CA3123078A1 (https=) |
| IL (1) | IL283931A (https=) |
| MX (1) | MX2021006933A (https=) |
| WO (1) | WO2020123824A1 (https=) |
| ZA (1) | ZA202104166B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113453677A (zh) | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
| IL298907A (en) * | 2020-06-12 | 2023-02-01 | Huyabio Int Llc | Administering sulcardin for the treatment of acute atrial fibrillation |
| CN114984004B (zh) * | 2022-05-25 | 2023-09-12 | 扬州中宝药业股份有限公司 | 硫酸舒欣啶在制备抗脓毒症药物中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1939298A (zh) | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| JP5308333B2 (ja) | 2006-06-30 | 2013-10-09 | シグマ−タウ レア ディジージズ エスィアー | Ｌ−アスパラギナーゼｉｉを産生する組換え宿主 |
| EP2468869B1 (en) | 2007-01-31 | 2015-03-18 | Pfenex Inc. | Bacterial leader sequences for increased expression |
| EP2501380B1 (en) * | 2009-11-17 | 2016-01-27 | Huya Bioscience International LLC | Slow infusion of sulcardine and its salts |
| EP2501381B1 (en) * | 2009-11-17 | 2017-07-26 | Huya Bioscience International LLC | Treatment of atrial fibrillation |
| KR20130072201A (ko) | 2010-03-30 | 2013-07-01 | 피페넥스 인크. | 재조합 독소 단백질의 고수준 발현 |
| KR102092225B1 (ko) | 2014-04-30 | 2020-03-23 | 주식회사 엘지화학 | 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터 |
| CN107532190B (zh) | 2014-12-01 | 2021-07-09 | 菲尼克斯公司 | 用于肽生产的融合伴侣 |
| AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| EP3573602A4 (en) | 2017-01-26 | 2020-09-16 | Triastek, Inc. | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES |
| CN113453677A (zh) | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
-
2019
- 2019-12-12 CN CN201980092127.1A patent/CN113453677A/zh active Pending
- 2019-12-12 CA CA3123078A patent/CA3123078A1/en active Pending
- 2019-12-12 KR KR1020217021861A patent/KR20210135990A/ko not_active Ceased
- 2019-12-12 JP JP2021534215A patent/JP2022514537A/ja active Pending
- 2019-12-12 MX MX2021006933A patent/MX2021006933A/es unknown
- 2019-12-12 AU AU2019397511A patent/AU2019397511B2/en active Active
- 2019-12-12 WO PCT/US2019/066003 patent/WO2020123824A1/en not_active Ceased
- 2019-12-12 US US16/712,677 patent/US11364223B2/en active Active
- 2019-12-12 EP EP19836740.1A patent/EP3893870A1/en active Pending
-
2021
- 2021-06-13 IL IL283931A patent/IL283931A/en unknown
- 2021-06-17 ZA ZA2021/04166A patent/ZA202104166B/en unknown
-
2022
- 2022-05-23 US US17/750,944 patent/US11883380B2/en active Active
-
2023
- 2023-12-19 US US18/545,558 patent/US12357611B2/en active Active
-
2025
- 2025-06-16 US US19/239,746 patent/US20250302805A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022514537A5 (https=) | ||
| JP2015526458A5 (https=) | ||
| JP2020529996A5 (https=) | ||
| JP5796959B2 (ja) | 関節炎における痛みの治療のためのタペンタドール | |
| JP2024540183A5 (https=) | ||
| JPS60188323A (ja) | 心筋虚血治療用医薬組成物 | |
| WO2009150535A1 (en) | Dronedarone for the prevention of permanent atrial fibrillation | |
| JP2021527031A5 (https=) | ||
| JP2012502047A (ja) | 心房細動を治療する方法 | |
| JP2018537513A5 (https=) | ||
| JP2020533296A5 (https=) | ||
| JP2019529570A5 (https=) | ||
| JP2024531188A5 (https=) | ||
| JP2023553253A5 (https=) | ||
| JP2022514537A (ja) | 急性心房細動の処置のためのサルカルディン投与 | |
| JP2023549849A5 (https=) | ||
| JP2010535159A (ja) | レオヌリンの使用およびその組成物 | |
| JP2023546140A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2020531543A5 (https=) | ||
| JP2019531286A5 (https=) | ||
| CN113876775B (zh) | 一种青藤碱或其药物可接受的盐作为治疗动脉性肺动脉高压药物的用途 | |
| JP2024532957A5 (https=) | ||
| WO2018163119A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| JP2022518527A5 (https=) |